Effects of Finerenone, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, on Cardiovascular Disease, Chronic Kidney Disease, and Blood Pressure
Jonathan D. Ravid, Luke J. Laffin
Topics & Concepts
MedicineMineralocorticoid receptorKidney diseaseDiseaseInternal medicineClinical trialBioinformaticsIntensive care medicineReceptorBiologyHormonal Regulation and HypertensionCardiovascular, Neuropeptides, and Oxidative Stress ResearchBlood Pressure and Hypertension Studies